A citation-based method for searching scientific literature

Ajay Varanasi, Natalie Bellini, Deepti Rawal, Mehul Vora, Antoine Makdissi, Sandeep Dhindsa, Ajay Chaudhuri, Paresh Dandona. Eur J Endocrinol 2011
Times Cited: 97



Vandana S Raman, Kimberly J Mason, Luisa M Rodriguez, Krishnavathana Hassan, Xiaoying Yu, Lisa Bomgaars, Rubina A Heptulla. Diabetes Care 2010
Times Cited: 60




List of shared articles



Times cited

Current issues in GLP-1 receptor agonist therapy for type 2 diabetes.
Zachary T Bloomgarden, Lawrence Blonde, Alan J Garber, Carol H Wysham. Endocr Pract 2012
7


Adjuvant Liraglutide and Insulin Versus Insulin Monotherapy in the Closed-Loop System in Type 1 Diabetes: A Randomized Open-Labeled Crossover Design Trial.
Jeniece Trast Ilkowitz, Ranjitha Katikaneni, Martin Cantwell, Neesha Ramchandani, Rubina A Heptulla. J Diabetes Sci Technol 2016
12


Efficacy and safety of exenatide once weekly: an overview of the DURATION trials.
Christophe Em De Block, Luc F Van Gaal. Expert Rev Endocrinol Metab 2012
2

β-Cell differentiation and regeneration in type 1 diabetes.
L Ding, C Gysemans, C Mathieu. Diabetes Obes Metab 2013
17


The combination of insulin and GLP-1 analogues in the treatment of type 2 diabetes.
M M van der Klauw, B H R Wolffenbuttel. Neth J Med 2012
7

GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand?
Djordje S Popovic, Edita Stokic, Stevan L Popovic. Curr Pharm Des 2015
4

An update on the pharmacotherapy options for pediatric diabetes.
M Loredana Marcovecchio, Francesco Chiarelli. Expert Opin Biol Ther 2014
3

Once-weekly exenatide as adjunct treatment of type 1 diabetes mellitus in patients receiving continuous subcutaneous insulin infusion therapy.
Andrea N Traina, Melinda E Lull, Adrian C Hui, Toni M Zahorian, Jane Lyons-Patterson. Can J Diabetes 2014
32

GLP-1 Agonists in Type 1 Diabetes Mellitus.
Kristin M Janzen, Taylor D Steuber, Sarah A Nisly. Ann Pharmacother 2016
15

The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus.
Kashif M Munir, Stephen N Davis. Expert Opin Pharmacother 2015
11

Novel blood glucose lowering therapies for managing type 1 diabetes in paediatric patients.
Anda Mihaela Naciu, Paolo Pozzilli. Expert Opin Pharmacother 2018
1


Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label study.
K V S Hari Kumar, Altamash Shaikh, Pitambar Prusty. Diabetes Res Clin Pract 2013
59

Adjunctive therapy for glucose control in patients with type 1 diabetes.
Kira Harris, Cassie Boland, Lisa Meade, Dawn Battise. Diabetes Metab Syndr Obes 2018
8

Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm.
Venkat Sasidhar Renukuntla, Neesha Ramchandani, Jeniece Trast, Martin Cantwell, Rubina A Heptulla. J Diabetes Sci Technol 2014
26






Can GLP-1 preparations be used in children and adolescents with diabetes mellitus?
Naim Shehadeh, Eena Daich, Nehama Zuckerman-Levin. Pediatr Endocrinol Rev 2014
4


Management of Severe Insulin Resistance in Patients with Type 1 Diabetes.
Rebecca Schechter, Sirimon Reutrakul. Curr Diab Rep 2015
8


Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus.
Justinne Guyton, Michelle Jeon, Amie Brooks. Am J Health Syst Pharm 2019
0